Nolan Sigal

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Nolan Sigal

Earlier roles on record: Board Member at Rein Therapeutics, Inc. (RNTX) until February 29, 2024. Rein Therapeutics, Inc. reported in an 8-K filed March 1, 2024 that Nolan Sigal resigned as member of the Board of Directors, effective February 29, 2024.

“On February 29, 2024, Nolan Sigal, M.D., Ph.D., notified Aileron Therapeutics, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), effective immediately.”

Rein Therapeutics, Inc. Form 8-K, filed March 1, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Nolan Sigal's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Rein Therapeutics, Inc. (RNTX)
Board Member

Proxy statement

Start not stated–2024-02-29

Company network

Recorded roles and call appearances connecting this person to public companies.

Rein Therapeutics, Inc.

RNTX

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: member of the Board of Directors Rein Therapeutics, Inc. (RNTX)
2024-02-29